Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway
Stem Cell Research & Therapy volume 12, Article number: 529 (2021)
Retraction Note to: Stem Cell Research & Therapy (2021) 12:115 https://doi.org/10.1186/s13287-021-02183-2
The authors have retracted this article. After publication the authors became aware of issues with two of the figures, specifically:
In Fig. 5c the echocardiography images for 1 week and 3 weeks for the MI + HG group had been duplicated owing to an error in the assembly of the figure.
In Fig. 3a the bands for Beclin 1 had been constructed by using the bands from P21 in Fig. 2e during assembly of the figure.
All authors agree with this retraction.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhang, F., Gao, F., Wang, K. et al. Retraction Note to: MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway. Stem Cell Res Ther 12, 529 (2021). https://doi.org/10.1186/s13287-021-02606-0